Jeffrey L. Wade J.D.
Net Worth

Last updated:

What is Jeffrey L. Wade J.D. net worth?

The estimated net worth of Mr. Jeffrey L. Wade J.D. is at least $8,818,715 as of 28 Feb 2024. He owns shares worth $301,375 as insider and has received compensation worth at least $8,517,340 in Lexicon Pharmaceuticals, Inc..

What is the salary of Jeffrey L. Wade J.D.?

Mr. Jeffrey L. Wade J.D. salary is $655,180 per year as Pres & Chief Financial Officer in Lexicon Pharmaceuticals, Inc..

How old is Jeffrey L. Wade J.D.?

Mr. Jeffrey L. Wade J.D. is 60 years old, born in 1965.

What stocks does Jeffrey L. Wade J.D. currently own?

As insider, Mr. Jeffrey L. Wade J.D. owns shares in one company:

Company Title Shares Price per share Total value
Lexicon Pharmaceuticals, Inc. (LXRX) Pres & Chief Financial Officer 264,341 $1.14 $301,375

What does Lexicon Pharmaceuticals, Inc. do?

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

LXRX logo
LXRX
Lexicon Pharmaceuticals, Inc.
$1.14

Jeffrey L. Wade J.D. insider trading

Lexicon Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 11,177 N/A N/A
Option
Common Stock 49,113 N/A N/A
Option
Restricted Stock Units 37,274 N/A N/A
Option
Restricted Stock Units 11,177 N/A N/A
Option
Common Stock 37,274 N/A N/A
Option
Restricted Stock Units 49,113 N/A N/A
Purchase
Common Stock 10,000 $1.38 $13,800
Purchase
Common Stock 2,000 $2.33 $4,650
Purchase
Common Stock 10,000 $2.34 $23,350
Option
Restricted Stock Units 37,273 N/A N/A
Option
Restricted Stock Units 30,467 N/A N/A
Option
Restricted Stock Units 11,176 N/A N/A
Option
Common Stock 37,273 N/A N/A
Option
Common Stock 11,176 N/A N/A
Option
Common Stock 30,467 N/A N/A
Option
Common Stock 25,290 N/A N/A
Option
Restricted Stock Units 30,466 N/A N/A
Option
Common Stock 11,177 N/A N/A
Option
Common Stock 30,466 N/A N/A
Option
Restricted Stock Units 25,290 N/A N/A
Option
Restricted Stock Units 11,177 N/A N/A
Option
Restricted Stock Units 58,554 N/A N/A
Option
Common Stock 68,109 N/A N/A
Option
Common Stock 68,109 N/A N/A
Option
Restricted Stock Units 58,554 N/A N/A
Option
Restricted Stock Units 42,138 N/A N/A
Option
Common Stock 42,138 N/A N/A
Option
Common Stock 22,655 N/A N/A
Option
Restricted Stock Units 22,655 N/A N/A
Option
Restricted Stock Units 16,028 N/A N/A
Option
Restricted Stock Units 2,797 N/A N/A
Option
Restricted Stock Units 7,292 N/A N/A
Option
Common Stock 16,028 N/A N/A
Purchase
Common Stock 2,000 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 15,659 N/A N/A
Option
Common Stock 15,659 N/A N/A
Option
Common Stock 13,949 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 13,949 N/A N/A
Option
Common Stock 75,750 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 75,750 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 55,250 N/A N/A
Option
Common Stock 55,250 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 38,250 N/A N/A
Option
Common Stock 38,250 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 31,600 N/A N/A
Option
Common Stock 31,600 N/A N/A
Option
Common Stock 18,750 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 18,750 N/A N/A

Lexicon Pharmaceuticals key executives

Lexicon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: